 NEW YORK--BUSINESS WIRE--Schrödinger, Inc. Nasdaq: SDGR, whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery collaboration with Bristol Myers Squibb Company NYSE: BMY to discover, develop, and commercialize therapeutics in multiple disease areas. The multi-year collaboration will combine Schrödingers leading physics-based computational platform and drug discovery capabilities with Bristol Myers Squibbs expe 